Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.                                 Description
  2.1*          Business Combination Agreement, dated as of March 15, 2021, by and
              between Therapeutics Acquisition Corp., Bodhi Merger Sub, Inc. and
              POINT BioPharma Inc.
  10.1          Form of Sponsor Letter Agreement.




  *   Certain exhibits and schedules to this Exhibit have been omitted in
      accordance with Item 601(a)(5) of Regulation S-K. The Company agrees to
      furnish supplementally a copy of any omitted exhibit or schedule to the SEC
      upon its request.

© Edgar Online, source Glimpses